Novel Drug Delivery Systems: An Important Direction for Drug Innovation Research and Development
-
Published:2024-05-16
Issue:5
Volume:16
Page:674
-
ISSN:1999-4923
-
Container-title:Pharmaceutics
-
language:en
-
Short-container-title:Pharmaceutics
Author:
Chen Qian1, Yang Zhen1, Liu Haoyu1, Man Jingyuan1, Oladejo Ayodele Olaolu12, Ibrahim Sally13, Wang Shengyi1ORCID, Hao Baocheng1ORCID
Affiliation:
1. Key Laboratory of New Animal Drug Project, Gansu Province, Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture and Rural Affairs, Lanzhou Institute of Husbandry and Pharmaceutical Sciences of Chinese Academy of Agriculture Sciences, Lanzhou 730050, China 2. Department of Animal Health Technology, Oyo State College of Agriculture and Technology, Igboora 201003, Nigeria 3. Department of Animal Reproduction and AI, Veterinary Research Institute, National Research Centre, Dokki 12622, Egypt
Abstract
The escalating demand for enhanced therapeutic efficacy and reduced adverse effects in the pharmaceutical domain has catalyzed a new frontier of innovation and research in the field of pharmacy: novel drug delivery systems. These systems are designed to address the limitations of conventional drug administration, such as abbreviated half-life, inadequate targeting, low solubility, and bioavailability. As the disciplines of pharmacy, materials science, and biomedicine continue to advance and converge, the development of efficient and safe drug delivery systems, including biopharmaceutical formulations, has garnered significant attention both domestically and internationally. This article presents an overview of the latest advancements in drug delivery systems, categorized into four primary areas: carrier-based and coupling-based targeted drug delivery systems, intelligent drug delivery systems, and drug delivery devices, based on their main objectives and methodologies. Additionally, it critically analyzes the technological bottlenecks, current research challenges, and future trends in the application of novel drug delivery systems.
Funder
The National Key R&D Program of China
Reference224 articles.
1. The evolution of commercial drug delivery technologies;Vargason;Nat. Biomed. Eng.,2021 2. Enrique, N., Alberto, O., Antonio, J., Bravo, I., and Alonso-Moreno, C. (2021). Polyester polymeric nanoparticles as platforms in the development of novel nanomedicines for cancer treatment. Cancers, 13. 3. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy;Huang;Acta. Biomater.,2019 4. Su, X., Cao, Y., Liu, Y., Ouyang, B.S., Ning, B., Wang, Y., Guo, H.S., Pang, Z.Q., and Shen, S. (2021). Localized disruption of redox homeostasis boosting ferroptosis of tumor by hydrogel delivery system. Mater. Today. Bio., 12. 5. Liposome: Classification, preparation, and applications;Abolfazl;Nanoscale Res. Lett.,2013
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|